AT-406 is a potent, orally bioavailable Smac mimetic that specifically targets inhibitor of apoptosis proteins (IAPs). It interacts with XIAP, cIAP1, and cIAP2, demonstrating high affinity for these proteins. This compound's structural design allows it to effectively bind and modulate the activity of these IAPs.
Usually ships within 24 hours.